Opioid agonists differentially regulate μ-opioid receptors and trafficking proteins in vivo

Molecular Pharmacology

Volumn 62, Issue 6, 2002, Pages 1464-1470

  Patel, Minesh B ^a   Patel, Chintan N ^a   Rajashekara, Vikram ^a   Yoburn, Byron C ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; G PROTEIN COUPLED RECEPTOR KINASE 2; MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR; OPIATE AGONIST;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG BINDING; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; SPINAL CORD;

ANALGESICS, OPIOID; ANIMALS; BETA-ADRENERGIC RECEPTOR KINASE; BINDING SITES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ETORPHINE; MALE; MICE; MORPHINE; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

EID: 0036892880     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.6.1464     Document Type: Article

References (38)

1. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, Grandy DK, and Williams JT (2002) μ-opioid receptors: Ligand-dependent activation of potassium conductance, desensitization and internalization. J Neurosci 22:5769-5776.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Brodsky M, Elliott K, Hynansky A, and Inturrisi CE (1995) CNS levels of mu-opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone. Brain Res Bull 38:135-141.
4. Burd AL, El-Kouhen R, Erickson LJ, Loh HH, and Law PY (1998) Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the μ-opioid receptor. J Biol Chem 273:34488-34495.
5. Burford NT, Tolbert LM, and Sadee W (1998) Specific G protein activation and μ-oploid receptor internalization caused by morphine, DAMGO and endomorphine I. Eur J Pharmacol 342:123-126.
6. Carman CV and Benovic JL (1998) G-protein-coupled receptors: Turn-ons and turn-offs. Curr Opin Neurobiol 8:335-344.
7. Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, and Gessa GL (1997) Chronic morphine and naltrexone fail to modify μ-oploid receptor mRNA levels in the rat brain. Brain Res Mol Brain Res 45:149-153.
8. Duttaroy A and Yoburn BC (1995) The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82:1226-1236.
9. Duttaroy A, Shen J, Shah S, Chen B, Sehba F, Carroll J, and Yoburn BC (1999) Opioid receptor upregulation in μ-opioid receptor deficient CXBK and outbred Swiss Webster mice. Life Sci 65:113-123.
10. Duttaroy A and Yoburn BC (2000) In vivo regulation of μ-opioid receptor density and gene expression in CXBK and outbred swiss webster mice. Synapse 37:118-124.
11. Gaborik Z, Szaszak M, Szidonya L, Balla B, Paku S, Catt KJ, Clark AJ, and Hunyady L (2001) β-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol Pharmacol 59:239-247.
12. Gagnon AW, Kallal L, and Benovic JL (1998) Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the β2-adrenergic receptor. J Biol Chem 273:6976-6981.
13. Gomes BA, Shen J, Stafford K, Patel M, and Yoburn BC (2002) μ-opioid receptor down-regulation and tolerance are not equally dependent upon G-protein signaling, Pharmacol Biochem Behav 72:273-278.
14. Hasbi A, Allouche S, Sichel F, Stanasila L, Massotte D, Landemore G, Polastron J, and Jauzac P (2000) Internalization and recycling of δ-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism. J Pharmacol Exp Ther 293:237-247.
15. Hurle MA (2001) Changes in the expression of G protein-coupled receptor kinases and β-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J Neurochem 77:486-492.
16. Jenab S, Kest B, and Inturrisi CE (1995) Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment. Brain Res 691:69-75.
17. Kato S, Fukuda K, Morikawa H, Shoda T, Mima H, and Mori K (1998) Adaptations to chronic agonist exposure of μ-opioid receptor-expressing Chinese hamster ovary cells. Eur J Pharmacol 345:221-228.
18. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 9:19021-19024.
19. Kim DS, Chin H, and Klee WA (1995) Agonist regulation of the expression of the delta opioid receptor in NG108-15 cells. FEBS Lett 376:11-14.
20. Krupnick JG and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
21. Lazari MF, Liu X, Nakamura K, Benovic JL, and Ascoli M (1999) Role of G protein-coupled receptor kinases on the agonist-induced phosphorylation and internalization of the follitropin receptor. Mol Endocrinol 13:866-878.
22. Li JG, Benovic JL, and Liu-Chen LY (2000) Mechanisms of agonist-induced down-regulation of the human κ-opioid receptor: Internalization is required for down-regulation. Mol Pharmacol 58:795-801.
23. Patel M, Gomes B, Patel C, and Yoburn BC (2002) Antagonist-induced μ-opioid receptor upregulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord. Eur J Pharmacol 446:37-42.
24. Sehba F, Duttaroy A, Shah S, Chen B, Carroll J, and Yoburn BC (1997) In vivo homologous regulation of μ-opioid receptor gene expression in the mouse. Eur J Pharmacol 339:33-41.
25. Shen J, Benedict GA, Gallagher A, Stafford K, and Yoburn BC (2000) Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced μ-opioid receptor down-regulation and tolerance in mice. Synapse 38:322-327.
26. Stafford K, Gomes BA, Shen J, and Yoburn BC (2001) μ-opioid receptor down-regulation contributes to opioid tolerance in vivo. Pharmacol Biochem Behav 69:233-237.
27. Terwilliger RZ, Ortiz J, Guitart X, and Nestler EJ (1994) Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coernleus. J Neurochem 63:1983-1986.
28. Trafton JA, Abbadie C, Marek K and Basbaum (2000) AI. Postsynaptic signaling via the μ-opioid receptor: Responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J Neurosci 20:8578-8584.
29. Unterwald EM, Rubenfeld JM, Imai Y, Wang JB, Uhl GR, and Kreek MJ (1995) Chronic opioid antagonist administration upregulates μ opioid receptor binding without altering μ opioid receptor mRNA levels. Brain Res Mol Brain Res 33:351-355.
30. Van Bockstaele EJ and Commons KG (2001) Internalization of μ-opioid receptors produced by etorphine in the rat locus coeruleus. Neuroscience 108:467-477.
31. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc Natl Acad Sci USA 95:9914-9919.
32. Whistler JL, Chuang H, Chu P, Jan LY, and von Zastrow M (1999) Functional dissociation of opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
33. Whistler JL, Tsao P, and von Zastrow M (2001) A phosphorylation-regulated brake mechanism controls the initial endocytosis of opioid receptors but is not required for post-endocytic sorting to lysosomes. J Biol Chem 276:34331-34338.
34. Yabaluri N and Medzihradsky F (1997) Down-regulation of μ-opioid receptor by full but not partial agonists are independent of G protein coupling. Mol Pharmacol 52:896-902.
35. Yoburn BC, Billings B, and Duttaroy A (1993) Opioid receptor regulation in mice. J Pharmacol Exp Ther 265:314-320.
36. Yoburn BC, Shah S, Chan K, Duttaroy A, and Davis T (1995) Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity. Pharmacol Biochem Behav 51:535-539.
37. Zaki PA, Keith DA Jr, Brine GA, and Carroll FI (2000) Ligand-induced changes in surface μ-opioid receptor number: Relationship to G protein activation? J Pharmacol Exp Ther 292:1127-1134.
38. Zhang J, Ferguson SG, Barak LS, Bodduluri SR, Laporte SA, Law PY, and Caron MG (1998) Role for G-protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.